title: Four years follow-up of 101 children with melamine-related urinary stones.
abstract: The melamine-contaminated milk powder incidence occurred in China in 2008. Many studies have been published regarding the epidemiology, clinical symptoms, diagnosis and treatment of melamine-related urinary stones. The objective of this study is to follow-up the effects of melamine-contaminated milk powder consumption on kidney and body growth in children with melamine-related urinary stones 4 years ago. One hundred and one children with melamine-related urinary stones were followed up by urinalysis, renal function tests and urinary ultrasonography. The data of body weight and height, clinical signs and complications were collected. Eighty normal children without the history of consuming melamine-contaminated milk powder were collected as controls. Eighty-one children with melamine-related urinary stones were successfully followed up. Of 45 cases with melamine-related urinary stones treated conservatively after discharge, 34 disappeared completely, 6 dissolved partially, 1 increased in size and 4 did not change at 4 years follow-up. The percentages of under-height and under-weight infants were significantly higher in melamine-related urinary stones group compared to the controls, respectively (p < 0.05). Routine blood, renal and bladder function tests as well as urinalysis were normal in all children. No urological tumors were detected. No noticeable impact of melamine-related urinary stones on kidney and bladder was found at 4 years follow-up. However, whether or not melamine-related urinary stones had effect on body growth needs follow-up in future.
authors.forename: Li
authors.initials: L
authors.lastname: Yang
authors.forename: Jian Guo
authors.initials: JG
authors.lastname: Wen
authors.forename: Jian Jun
authors.initials: JJ
authors.lastname: Wen
authors.forename: Zhi Qiang
authors.initials: ZQ
authors.lastname: Su
authors.forename: Wen
authors.initials: W
authors.lastname: Zhu
authors.forename: Chen Xu
authors.initials: CX
authors.lastname: Huang
authors.forename: Si Long
authors.initials: SL
authors.lastname: Yu
authors.forename: Zhan
authors.initials: Z
authors.lastname: Guo
mesh_terms: D000818:Animals; D016022:Case-Control Studies; D002648:Child; D002657:Child Development; D002675:Child, Preschool; D002681:China; D005260:Female; D005500:Follow-Up Studies; D005506:Food Contamination; D006801:Humans; D007223:Infant; D041943:Infant Formula; D007668:Kidney / Q000473:pathology; D008297:Male; D008892:Milk / Q000633:toxicity*; D011208:Powders; D014227:Triazines / Q000633:toxicity*; D014545:Urinary Calculi / Q000209:etiology* / Q000473:pathology / Q000628:therapy*
chemical_list: D011208:Powders; D014227:Triazines; C011907:melamine
references.citation: World J Pediatr. 2009 Feb;5(1):31-5
references.pmid: 19172329
references.citation: J Clin Invest. 1997 Mar 15;99(6):1287-94
references.pmid: 9077538
references.citation: Urol Int. 2011;87(4):429-33
references.pmid: 22057293
references.citation: J Proteome Res. 2012 Apr 6;11(4):2544-50
references.pmid: 22401608
references.citation: N Engl J Med. 2009 Mar 12;360(11):1157-8
references.pmid: 19196667